Effect of andaliman (Zanthoxylum acanthopodium DC.) ethanol extract on doxorubicin-induced toxicity on hematology in male rats
Abstract
Introduction: Doxorubicin is one of the chemotherapy drugs that have harmful effects on blood hematology. Blood hematological diseases are caused by its adverse effects and anticancer properties. The antioxidant properties of several plants have been reported to be closely related to reduced toxicity in blood hematology. Andaliman (Zanthoxylum acanthopodium) ethanolic extract (AEE) is thought to reduce the toxicity of doxorubicin due to the antioxidant properties of its secondary metabolite content. This study aimed to determine the effect of AEE on doxorubicin-induced rats and its effect on blood cells. Materials and Method: A total of 24 male rats were divided into 6 groups: (1) Normal group; (2) 0.5% Na-CMC group; (3) 50 mg/kg BW quercetin group; (4) AEE 75 mg/kg BW group; (5) AEE 150 mg/kg BW group; and (6) AEE group 300 mg/kg BW administered orally for 9 days. On days 8 and 9, doxorubicin 10 mg/kg BW was administered. Rats were sacrificed for blood collection, and measured at the Integrated Laboratory of the USU Hospital. Results: AEE reduces the toxicity of doxorubicin on blood parameters. Furthermore, it affects Hb, white blood cells, platelet cells, monocytes, lymphocytes, neutrophils, and several related protein metabolisms as well as organ damage. Dose 150 or 300 mg/kg AEE reduce all blood toxins to near-normal levels and decrease the lymphocyte and neutrophil suppressive activity of doxorubicin. Conclusion: Andaliman ethanol extract can improve Hb count, white blood cells, platelet cells, monocytes, lymphocytes, neutrophils, protein metabolism, and organ damage. Furthermore, AEE can be used in combination with doxorubicin to reduce its hematological toxicity.
Keywords: toxicity, hematology, doxorubicin, andaliman, Zanthoxylum acanthopodium, extract
Keywords:
toxicity, hematology, doxorubicin, andaliman, Zanthoxylum acanthopodium, ExtractDOI
https://doi.org/10.22270/jddt.v13i3.5975References
Kemenkes RI. Apa itu Kanker? - Direktorat P2PTM. Published 2019. Accessed September 2, 2022. http://p2ptm.kemkes.go.id/infographic-p2ptm/penyakit-kanker-dan-kelainan-darah/page/14/apa-itu-kanker
UICC. GLOBOCAN 2020: New Global Cancer Data | UICC. Published 2020. Accessed September 2, 2022. https://www.uicc.org/news/globocan-2020-new-global-cancer-data
Abushouk AI, Ismail A, Salem AMA, Afifi AM, Abdel-Daim MM. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy. 2017; 90:935-946. https://doi.org/10.1016/j.biopha.2017.04.033
Sleijfer S, Rizzo E, Litière S, et al. Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database. Acta Oncol (Madr). 2018; 57(8):1117-1126. https://doi.org/10.1080/0284186X.2018.1449248
Serna-Thomé G, Castro-Eguiluz D, Fuchs-Tarlovsky V, et al. Use of Functional Foods and Oral Supplements as Adjuvants in Cancer Treatment. Rev Inves Clin. 2018; 70:136-182. https://doi.org/10.24875/RIC.18002527
Rezk YA, Balulad SS, Keller RS, Bennett JA. Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart. Am J Obstet Gynecol. 2006; 194(5):23-26. https://doi.org/10.1016/j.ajog.2005.11.030
Okagu IU, Ndefo JC, Aham EC, Teodor E. Zanthoxylum Species : A Review of Traditional Uses , Phytochemistry and Pharmacology in Relation to Cancer , Infectious Diseases and Sickle Cell Anemia. 2021; 12(September):1-18. https://doi.org/10.3389/fphar.2021.713090
Asbur Y, Khairunnisyah K. Pemanfatan andaliman (Zanthoxylum acanthopodium DC) sebagai tanaman penghasil minyak atsiri. Kultivasi. 2018; 17(1):537-543. https://doi.org/10.24198/kultivasi.v17i1.15668
Sihotang Y, Satria D, Silalahi J, Hadisahputra S, Anjelisa P. Cardioprotective Effect Of Ethylacetate Extract Of Zanthoxylum acanthopodium DC. Against Doxorubicin-Induced Cardiotoxicity in Rats. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 1, Jan. 2017, pp. 95-98, https://doi.org/10.22159/ajpcr.2017.v10i1.14163
Raharjo S, Mada UG. Antiradical activity of andaliman ( Zanthoxylum achanthopodium DC ) fruit extracts. 2017; (July).
Chatterjee K, Zhang J, Honbo N, Karliner JS. Fax +41 61 306 12 34 E-Mail karger@karger.ch Doxorubicin Cardiomyopathy. Cardiology. 2010; 115:155-162. https://doi.org/10.1159/000265166
National Institute of Health. Common Terminology Criteria for Adverse Events ( CTCAE ). NIH Publication. 2010; 0:0-71.
Verma R, Foster RE, Horgan K, et al. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Research. Published online 2016:1-12. https://doi.org/10.1186/s13058-015-0669-x
Haron NWMR, Yusuf JSZ. Changes in Cellular Immunity during Chemotherapy for Primary Breast Cancer with Anthracycline Regimens. 2007; 19:716-723. https://doi.org/10.1179/joc.2007.19.6.716
Wise J. Chemotherapy could make breast cancer patients more vulnerable to common infections. 2016; 407(January):13058. https://doi.org/10.1136/bmj.i407
Tine Y, Yang Y, Renucci F, Costa J, Wélé A, Paolini J. LC-MS/MS analysis of flavonoid compounds from Zanthoxylum zanthoxyloides extracts and their antioxidant activities. Nat Prod Commun. 2017; 12(12):1865-1868. https://doi.org/10.1177/1934578X1701201213
Arsita E V., Saragih DE, Aldrin K. Anticancer potential from ethanol extract of Zanthoxylum acanthopodium DC. seed to against MCF-7 cell line. IOP Conf Ser Earth Environ Sci. 2019; 293(1). https://doi.org/10.1088/1755-1315/293/1/012016
Published
Abstract Display: 534 
PDF Downloads: 611 PDF Downloads: 54 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.